InsidersTradesSigma
Explore the complete record of transactions filed by Heffron Nicola, Chief Executive Officer. Director active across 1 companies, notably 2seventy bio, Inc.. In total, 7 disclosures have been published. Total volume traded: €27k. The latest transaction was disclosed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations
Nicola Heffron is the Chief Operating Officer at 2seventy bio, Inc. She is responsible for the company's operations and the implementation of its strategy. 2seventy bio, Inc. is a biopharmaceutical company specializing in developing innovative therapies.